Bank of America
CTNM

Bank of America’s Contineum Therapeutics CTNM Stock Holding History

Bank of America’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$620K Buy
47,449
+38,180
+412% +$512K ﹤0.01% 4782
2025
Q4 		$106K Buy
9,269
+2,033
+28% +$23.2K ﹤0.01% 5603
2025
Q3 		$85K Buy
7,236
+6,030
+500% +$48.6K ﹤0.01% 6663
2025
Q2 		$4.79K Sell
1,206
-4,563
-79% -$19.8K ﹤0.01% 7302
2025
Q1 		$40.3K Sell
5,769
-3,363
-37% -$30.6K ﹤0.01% 6803
2024
Q4 		$134K Buy
9,132
+3,542
+63% +$56.1K ﹤0.01% 6282
2024
Q3 		$107K Buy
5,590
+1,123
+25% +$21.5K ﹤0.01% 6301
2024
Q2 		$78.7K Buy
+4,467
New +$71.9K ﹤0.01% 6356

Other funds holding CTNM

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of America's CTNM Position: Q1 2026 in Review

Bank of America increased its Contineum Therapeutics (CTNM) stake by 412% in Q1 2026, buying an estimated $512K and bringing the position to 47,449 shares worth $620K. The position accounts for ﹤0.01% of the portfolio, ranked #4782.

Bank of America first reported a position in CTNM in Q2 2024 and has held it in 8 quarters since. 90 funds tracked by Wall St. Rank hold CTNM as of Q1 2026.

  • Bank of America held 47,449 shares of Contineum Therapeutics worth $620K as of Q1 2026.
  • Bank of America bought 38,180 Contineum Therapeutics shares in Q1 2026, an estimated $512K.
  • Contineum Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4782 holding.
  • Bank of America first reported a position in Contineum Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 90 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.